Cardiac device therapy

antidepressants vs placebo

16 studies (1,125,900 patients) provide low-certainty evidence for benefit of antidepressants for the outcome in Cardiac pacemaker twiddler syndrome.

subcutaneous implantable cardioverter-defibrillators (s-icds) vs placebo

2 studies (6,892 patients) provide low-certainty evidence against benefit of subcutaneous implantable cardioverter-defibrillators (s-icds) for the outcome in Premature battery depletion.

crt-d device vs placebo

2 studies (1,699 patients) provide low-certainty evidence against benefit of crt-d device for the outcome in cardiac implantable electronic device (cied) infection.

conduction system pacing (csp) vs placebo

4 studies (214 patients) provide low-certainty evidence for benefit of conduction system pacing (csp) for the outcome in permanent pacemaker indication.

icd implantation vs placebo

3 studies (114,484 patients) provide insufficient evidence with mixed findings regarding icd implantation for the outcome in complication aspects.

cephalosporium roseum extract vs placebo

2 studies (228 patients) provide insufficient evidence with mixed findings regarding cephalosporium roseum extract for the outcome in permanent pacemaker implantation date.

subcutaneous implantable cardioverter defibrillator (s-icd) vs placebo

2 studies (5,494 patients) provide insufficient evidence with mixed findings regarding subcutaneous implantable cardioverter defibrillator (s-icd) for the outcome in Wolff-Parkinson-White Syndrome.

subcutaneous implantable cardioverter defibrillator (s-icd) vs placebo · Inappropriate ICD Shocks

2 studies (5,494 patients) provide insufficient evidence with mixed findings regarding subcutaneous implantable cardioverter defibrillator (s-icd) for Inappropriate ICD Shocks in Wolff-Parkinson-White Syndrome.